Koninklijke Philips (PHG) Scheduled to Post Quarterly Earnings on Monday

Koninklijke Philips (NYSE:PHG) will be releasing its earnings data before the market opens on Monday, April 29th. Persons interested in participating in the company’s earnings conference call can do so using this link.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Monday, January 29th. The technology company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.41 by $0.03. The firm had revenue of $5.45 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Koninklijke Philips had a positive return on equity of 14.17% and a negative net margin of 2.53%. On average, analysts expect Koninklijke Philips to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Koninklijke Philips Price Performance

NYSE:PHG opened at $21.07 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. The stock’s 50 day moving average price is $20.43 and its two-hundred day moving average price is $20.91. The firm has a market capitalization of $19.57 billion, a price-to-earnings ratio of -36.96, a P/E/G ratio of 1.09 and a beta of 0.88. Koninklijke Philips has a 12-month low of $17.75 and a 12-month high of $24.27.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on PHG. StockNews.com upgraded Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research note on Thursday, February 8th. BNP Paribas lowered Koninklijke Philips from an “outperform” rating to an “underperform” rating in a research note on Wednesday, February 7th.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.